Horses deserve proven joint health products

See what makes Adequan i.m. safe and effective Brought to you by BloodHorse.com Partners | [View this promotional email in browser]( | [Unsubscribe]( Be sure to add partners@BloodHorse.com to your address book or safe sender list so our emails get to your inbox. See what makes Adequan® i.m. safe and effective [Keep your horse in the game] Keep your horse in the game Riders like you want to give your horses products you can trust to be safe and effective. As an FDA-approved product, Adequan® i.m. (polysulfated glycosaminoglycan) has been recommended millions of times1 to treat degenerative joint disease (DJD) in horses. And it’s still the only FDA-approved equine PSGAG available. [Discover Adequan® i.m.]( Why does FDA approval matter? Mobility matters, and so does what you are giving your horse. FDA-approval matters because it means Adequan® i.m. adheres to guidelines and Good Manufacturing Practices that ensure a quality product with quality ingredients. It is scientifically proven to:2,3 Reduce inflammation Restore synovial joint lubrication Repair joint cartilage Reverse the disease process [Learn about FDA approval]( INDICATIONS Adequan® i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. IMPORTANT SAFETY INFORMATION There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For full prescribing information, [click here.]( 1. Data on File, American Regent Animal Health, Inc. 2. Adequan® i.m. Package Insert, Rev 1/19. 3. Burba DJ, Collier MA, DeBault LE, Hanson-Painton O, Thompson HC, Holder CL: In vivo kinetic study on uptake and distribution of intramuscular tritium-labeled polysulfated glycosaminoglycan in equine body fluid compartments and articular cartilage in an osteochondral defect model. J Equine Vet Sci 1993; 13: 696-703 All trademarks are the property of American Regent, Inc. © 2022, American Regent, Inc. PP-AI-US-0859 You are receiving this e-mail because you requested to receive special promotions from BloodHorse and its partners. Please do not reply to this message. The partners@BloodHorse.com e-mail box is not monitored, and any e-mails received at that address will not be read. [Unsubscribe]( | [Contact Us]( | [Privacy Policy]( BloodHorse | 821 Corporate Drive | Lexington, KY 40503 | 800-582-5604